Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
Marshall CJ, Nallaratnam M, Mocatta T, Smyth D, Richards M, Elliott JM, Blake J, Winterbourn CC, Kettle AJ, McClean DR.
Am J Cardiol. 2010 Aug 1;106(3):316-22. PMID: 20643239
Prognostic Value of Plasma Myeloperoxidase in ESRD Patients.
Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE.
Am J Kidney Dis. 2010 Jul 15. [Epub ahead of print]. PMID: 20638167
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.
Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS ; Committee on Standardization of Markers of Cardiac Damage of the IFCC.
Clin Chem. 2005 May;51(5):810-24. Epub 2005 Mar 17. PMID: 15774573